BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ortho-McNeil-Janssen Pharmaceuticals, Inc. 

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: 609-730-2000 Fax: 609-730-2323


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Johnson & Johnson (JNJ) Unit Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ordered to Pay Record Breaking $327 Million Over Deceptive Risperdal Marketing Claims 6/6/2011 7:06:53 AM
Johnson & Johnson (JNJ)'s Ortho-McNeil-Janssen Pharmaceuticals, Inc. Neurologics Voluntarily Recalls Two Lots of TOPAMAX(R) 4/14/2011 10:57:45 AM
Receptos Announces License to Advance Structure-Based Drug Discovery for High-Value G-Protein Coupled Receptor (GPCR) Targets 1/6/2011 9:12:31 AM
Johnson & Johnson (JNJ)'s Ortho-McNeil-Janssen Pharmaceuticals, Inc. Dumps Arena Pharmaceuticals, Inc. (ARNA) Diabetes Drug, APD597 11/5/2010 8:05:38 AM
Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., Potential $480 Million in Milestones 9/9/2010 6:33:31 AM
Ortho-McNeil-Janssen Pharmaceuticals, Inc.'s Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain; Announces Positive Results 8/31/2010 8:13:48 AM
PriCara™, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice 7/19/2010 8:21:30 AM
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT) 6/28/2010 8:29:56 AM
Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical AB on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to Develop Diabetes Therapy 6/23/2010 11:08:58 AM
Diamyd Medical AB Signs Agreement for Diabetes Therapy with Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Diamyd to Get $45 Million, and up to $580 Million 6/22/2010 6:36:29 AM
123